DrugPatentWatch Database Preview
FENOFIBRATE - Generic Drug Details
What are the generic drug sources for fenofibrate and what is the scope of fenofibrate freedom to operate?
Fenofibrate
is the generic ingredient in nine branded drugs marketed by Lupin Atlantis, Sun Pharm Inds Ltd, Ajanta Pharma Ltd, Amerigen Pharms Ltd, Apotex Inc, Cnty Line Pharms, Dr Reddys Labs Sa, Glenmark Pharms Ltd, Impax Labs, Invagen Pharms, Mylan Pharms Inc, Rhodes Pharms, Torrent Pharms Ltd, Abbvie, Cipher Pharms Inc, Amneal Pharms Llc, Aurobindo Pharma Ltd, Cipla Ltd, Graviti Pharms, Hetero Labs Ltd Iii, Lupin Ltd, Mylan, Prinston Inc, Valeant Pharms North, Santarus Inc, Abbvie Inc, and Skyepharma Ag, and is included in thirty-nine NDAs. There are eighteen patents protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.There are forty-two drug master file entries for fenofibrate. Fifty-six suppliers are listed for this compound. There is one tentative approval for this compound.
Summary for FENOFIBRATE
| US Patents: | 18 |
| Tradenames: | 9 |
| Applicants: | 27 |
| NDAs: | 39 |
| Drug Master File Entries: | 42 |
| Suppliers / Packagers: | 56 |
| Bulk Api Vendors: | 97 |
| Clinical Trials: | 140 |
| Patent Applications: | 6,505 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for FENOFIBRATE |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for FENOFIBRATE |
| DailyMed Link: | FENOFIBRATE at DailyMed |
Pharmacology for FENOFIBRATE
| Ingredient-type | PPAR alpha |
| Drug Class | Peroxisome Proliferator Receptor alpha Agonist |
| Mechanism of Action | Peroxisome Proliferator-activated Receptor alpha Agonists |
Medical Subject Heading (MeSH) Categories for FENOFIBRATE
Synonyms for FENOFIBRATE
| 2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester |
| 2-[4-(4-CHLOROBENZOYL)PHENOXY]-2-METHYL-PROPANOIC ACID 1-METHYLETHYL ESTER |
| 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid,1-methylethylester |
| 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic acid 1-methyl-ethyl ester |
| 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic acid 1-methylethyl ester |
| 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic acid isopropyl ester |
| 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoicacidisopropylester |
| 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropionic Acid Isopropyl Ester |
| 2-[4-[(4-chlorophenyl)-oxomethyl]phenoxy]-2-methylpropanoic acid propan-2-yl ester |
| 2-1-methylethyl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate |
| 28073-EP2272825A2 |
| 28073-EP2272841A1 |
| 28073-EP2277565A2 |
| 28073-EP2277566A2 |
| 28073-EP2277567A1 |
| 28073-EP2277568A2 |
| 28073-EP2277569A2 |
| 28073-EP2277570A2 |
| 28073-EP2287163A1 |
| 28073-EP2287165A2 |
| 28073-EP2287166A2 |
| 28073-EP2292280A1 |
| 28073-EP2292620A2 |
| 28073-EP2295409A1 |
| 28073-EP2298742A1 |
| 28073-EP2298776A1 |
| 28073-EP2301923A1 |
| 28073-EP2301936A1 |
| 28073-EP2305678A1 |
| 28073-EP2314588A1 |
| 49562-28-9 |
| 562F289 |
| A827746 |
| AB00052196 |
| AB00052196_17 |
| AB00052196_18 |
| AB00052196-15 |
| AB00052196-16 |
| AB0012237 |
| AB03716 |
| AB2000298 |
| Abbott Brand of Procetofen |
| AbZ Brand of Procetofen |
| AC-4227 |
| AC1L1FPK |
| AJ-23609 |
| AK-88651 |
| AKOS005107777 |
| ALBB-028958 |
| Aliud Brand of Procetofen |
| AN-9654 |
| Ankebin |
| Antara |
| Antara (micronized) |
| Antara (TN) |
| Antara Micronized Procetofen |
| Anto Brand of Procetofen |
| ANW-41658 |
| API0003184 |
| API0025994 |
| API0026002 |
| API0026009 |
| Apo Feno Micro |
| Apo Fenofibrate |
| Apo-Feno-Micro |
| Apo-Fenofibrate |
| Apotex Brand of Procetofen |
| AX8021009 |
| AZU, Fenofibrat |
| Azupharma Brand of Procetofen |
| BC202978 |
| BDBM50085042 |
| betapharm Brand of Procetofen |
| BG0483 |
| BIDD:GT0574 |
| Bouchara Brand of Procetofen |
| BPBio1_000166 |
| BRD-K50388907-001-05-6 |
| BRD-K50388907-001-18-9 |
| BRN 2062462 |
| BSPBio_000150 |
| BSPBio_003162 |
| C-20905 |
| C07586 |
| C20H21ClO4 |
| CAS-49562-28-9 |
| CC-28385 |
| CCG-38996 |
| CCRIS 7282 |
| CHEBI:5001 |
| CHEMBL672 |
| CIP-Fenofibrate |
| clorofibrate |
| Controlip |
| CPD000058299 |
| CS-0892 |
| ct Arzneimittel Brand of Procetofen |
| ct-Arzneimittel Brand of Procetofen |
| CTK8B3039 |
| D00565 |
| D07XGR |
| DB01039 |
| Debat, Fenofibrate |
| DivK1c_000557 |
| DR001912 |
| DSSTox_CID_9874 |
| DSSTox_GSID_29874 |
| DSSTox_RID_78828 |
| DTXSID2029874 |
| durafenat |
| EBD45918 |
| EC 256-376-3 |
| EINECS 256-376-3 |
| Elasterate |
| Elasterin |
| EU-0100486 |
| F 6020 |
| F0674 |
| Fenobeta |
| Fenobrate |
| Fenocor-67 (TN) |
| Fenofanton |
| Fenofibrat AbZ |
| Fenofibrat AL |
| Fenofibrat AZU |
| Fenofibrat FPh |
| Fenofibrat Heumann |
| Fenofibrat Hexal |
| Fenofibrat ratiopharm |
| Fenofibrat Stada |
| fenofibrat von ct |
| Fenofibrat-ratiopharm |
| Fenofibrate (JAN/INN) |
| FENOFIBRATE (MICRONIZED) |
| FENOFIBRATE (MICRONIZED) (fenofibrate |
| Fenofibrate (Tricor, Trilipix) |
| Fenofibrate [INN:BAN] |
| Fenofibrate [USAN:USP:INN:BAN] |
| Fenofibrate Debat |
| Fenofibrate IDD-P |
| Fenofibrate MSD |
| Fenofibrate, >=99%, powder |
| Fenofibrate, analytical reference material |
| Fenofibrate, European Pharmacopoeia (EP) Reference Standard |
| Fenofibrate, pharmaceutical secondary standard; traceable to USP and PhEur |
| Fenofibrate, United States Pharmacopeia (USP) Reference Standard |
| fenofibrate; |
| Fenofibrato |
| Fenofibrato [INN-Spanish] |
| Fenofibratum |
| Fenofibratum [INN-Latin] |
| FENOFIBRITE |
| Fenogal |
| Fenogal (TN) |
| Fenoglide |
| Fenomax |
| Fenotard |
| Fibricor |
| Finofibrate |
| FNF |
| Fournier Brand of Procetofen |
| FT-0626400 |
| FT-0654669 |
| Fulcro |
| Gate Brand of Procetofen |
| Gen Fenofibrate |
| Gen-Fenofibrate |
| Genpharm Brand of Procetofen |
| GNR Pharma Brand of Procetofen |
| GNR-Pharma Brand of Procetofen |
| GP4850 |
| GRS-027 |
| GTPL7186 |
| Heumann Brand of Procetofen |
| Heumann, Fenofibrat |
| Hexal Brand of Procetofen |
| Hexal, Fenofibrat |
| HMS1568H12 |
| HMS1921B17 |
| HMS2090G20 |
| HMS2092B05 |
| HMS2095H12 |
| HMS2231B14 |
| HMS3259K03 |
| HMS3261B13 |
| HMS3369M13 |
| HMS3649D20 |
| HMS3655K12 |
| HMS501L19 |
| HSDB 7736 |
| HY-17356 |
| I06-0048 |
| IDI1_000557 |
| Isopropyl (4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl)propionate |
| Isopropyl (4''-(p-chlorobenzoyl)-2-phenoxy-2-methyl)propionate |
| Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoate |
| Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate |
| Isopropyl 2-(p-(p-chlorobenzoyl)phenoxy)-2-methylpropionate |
| isopropyl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoate |
| isopropyl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate |
| Isopropyl 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropionate |
| Isopropyl 2-[p-(p-chlorobenzoyl)phenoxy]-2-methylpropionate |
| J10318 |
| K-9221 |
| KBio1_000557 |
| KBio2_001730 |
| KBio2_004298 |
| KBio2_006866 |
| KBio3_002382 |
| KBioGR_000706 |
| KBioSS_001730 |
| Knoll Brand of Procetofen |
| KS-00000655 |
| LCP-Feno |
| LCP-FenoChol |
| LF 178 |
| LF-178 |
| LF178 |
| Lichtenstein Brand of Procetofen |
| Lipanthyl |
| Lipanthyl (TN) |
| Lipantil |
| Lipantil (TN) |
| Liparison |
| Lipidex |
| Lipidil |
| Lipidil (TN) |
| Lipidil Micro |
| Lipidil Supra |
| Lipidil Ter |
| Lipidil-Ter |
| Lipifen |
| Lipirex |
| Lipoclar |
| Lipofen |
| Lipofen (TN) |
| Lipofene |
| Liposit |
| Lipsin |
| Lofibra |
| Lofibra (TN) |
| Lopac-F-6020 |
| Lopac0_000486 |
| LP00486 |
| LS-121256 |
| Luxacor |
| MCULE-9460650238 |
| Merck dura Brand of Procetofen |
| METHYLETHYL 2-(4-[(4-CHLOROPHENYL)CARBONYL]PHENOXY)-2-METHYLPROPANOATE |
| methylethyl 2-{4-[(4-chlorophenyl)carbonyl]phenoxy}-2-methylpropanoate |
| MFCD00133314 |
| Micronized Procetofen, Antara |
| MLS000028515 |
| MLS001148191 |
| MLS002548878 |
| MolPort-002-887-051 |
| MS-2223 |
| MTW Brand of Procetofen |
| MTW Fenofibrat |
| MTW-Fenofibrat |
| NC00452 |
| NCGC00015437-01 |
| NCGC00015437-02 |
| NCGC00015437-03 |
| NCGC00015437-04 |
| NCGC00015437-05 |
| NCGC00015437-06 |
| NCGC00015437-07 |
| NCGC00015437-08 |
| NCGC00015437-09 |
| NCGC00015437-10 |
| NCGC00015437-11 |
| NCGC00015437-12 |
| NCGC00015437-13 |
| NCGC00015437-14 |
| NCGC00015437-16 |
| NCGC00015437-17 |
| NCGC00021475-03 |
| NCGC00021475-04 |
| NCGC00021475-05 |
| NCGC00021475-06 |
| NCGC00021475-07 |
| NCGC00021475-08 |
| NCGC00253945-01 |
| NCGC00261171-01 |
| NINDS_000557 |
| Nolipax |
| Novartis Brand of Procetofen |
| Novo Fenofibrate |
| Novo-Fenofibrate |
| Novopharm Brand of Procetofen |
| NSC 281319 |
| NSC-281319 |
| NSC-757822 |
| NSC281319 |
| NSC757822 |
| Nu Fenofibrate |
| Nu Pharm Brand of Procetofen |
| Nu-Fenofibrate |
| Nu-Pharm Brand of Procetofen |
| Opera_ID_328 |
| OR108780 |
| OR273579 |
| OR273580 |
| Pharmakon1600-01501010 |
| Pharmascience Brand of Procetofen |
| Pharmavit |
| Phenofibrate |
| PMS Fenofibrate Micro |
| PMS-Fenofibrate Micro |
| Prestwick_217 |
| Prestwick0_000275 |
| Prestwick1_000275 |
| Prestwick2_000275 |
| Prestwick3_000275 |
| Procetofen |
| Procetofen Reliant Brand |
| Procetofen, Antara Micronized |
| Procetofene |
| Procetoken |
| Proctofene |
| propan-2-yl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate |
| propan-2-yl 2-[4-(4-chlorophenyl)carbonylphenoxy]-2-methyl-propanoate |
| propan-2-yl 2-{4-[(4-chlorophenyl)carbonyl]phenoxy}-2-methylpropanoate |
| PROPAN-2-YL-2-(4-[(4-CHLOROPHENYL)CARBONYL]PHENOXY)-2-METHYLPROPANOATE |
| Propanoic acid, 2-(4-(4-chlorobenzoyl)phenoxy)-2-methyl-, 1-methylethyl ester |
| Propanoic acid, 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-, 1-methylethyl ester |
| Protolipan |
| PubChem17489 |
| Q Pharm Brand of Procetofen |
| Q-201111 |
| Q-Pharm Brand of Procetofen |
| ratiopharm Brand of Procetofen |
| Reliant Brand of Procetofen |
| s1794 |
| SAM002264613 |
| SBB037926 |
| SBI-0050470.P003 |
| SCHEMBL4670 |
| Schering Plough Brand of Procetofen |
| Schering-Plough Brand of Procetofen |
| Secalip |
| Sedufen |
| SMR000058299 |
| SPBio_001380 |
| SPBio_002369 |
| Spectrum_001250 |
| SPECTRUM1501010 |
| Spectrum2_001390 |
| Spectrum3_001431 |
| Spectrum4_000413 |
| Spectrum5_001479 |
| SR-01000000091 |
| SR-01000000091-16 |
| SR-01000000091-5 |
| ST085313 |
| Stada, Fenofibrat |
| Stadapharm Brand of Procetofen |
| Supralip |
| TC-130403 |
| TL8003296 |
| Tox21_110147 |
| Tox21_110147_1 |
| Tox21_300151 |
| Tox21_500486 |
| Tricor |
| TRICOR (MICRONIZED) |
| Tricor (TN) |
| Triglide |
| Triglide (TN) |
| U202363UOS |
| UNII-U202363UOS |
| United Drug Brand of Procetofen |
| YMTINGFKWWXKFG-UHFFFAOYSA-N |
| Z2768724415 |
| ZB014484 |
| ZINC584092 |
| ZX-AN079771 |
US Patents and Regulatory Information for FENOFIBRATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amerigen Pharms Ltd | FENOFIBRATE (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 209504-003 | Apr 30, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Prinston Inc | FENOFIBRATE | fenofibrate | TABLET;ORAL | 211080-002 | Aug 28, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Aurobindo Pharma Ltd | FENOFIBRATE | fenofibrate | TABLET;ORAL | 205118-002 | May 5, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021656-001 | Nov 5, 2004 | AB | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021656-001 | Nov 5, 2004 | AB | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||
| Santarus Inc | FENOGLIDE | fenofibrate | TABLET;ORAL | 022118-001 | Aug 10, 2007 | AB | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||
| Amerigen Pharms Ltd | FENOFIBRATE (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 209504-002 | Apr 30, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for FENOFIBRATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Cipher Pharms Inc | LIPOFEN | fenofibrate | CAPSULE;ORAL | 021612-003 | Jan 11, 2006 | ➤ Sign Up | ➤ Sign Up |
| Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021656-002 | Nov 5, 2004 | ➤ Sign Up | ➤ Sign Up |
| Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021656-002 | Nov 5, 2004 | ➤ Sign Up | ➤ Sign Up |
| Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021656-001 | Nov 5, 2004 | ➤ Sign Up | ➤ Sign Up |
| Abbvie Inc | TRICOR | fenofibrate | TABLET;ORAL | 021203-001 | Sep 4, 2001 | ➤ Sign Up | ➤ Sign Up |
| Abbvie | TRICOR (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 019304-002 | Feb 9, 1998 | ➤ Sign Up | ➤ Sign Up |
| Abbvie Inc | TRICOR | fenofibrate | TABLET;ORAL | 021203-003 | Sep 4, 2001 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for FENOFIBRATE
| Country | Document Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 1194140 | ➤ Sign Up |
| Portugal | 1523983 | ➤ Sign Up |
| South Africa | 200200169 | ➤ Sign Up |
| European Patent Office | 1128814 | ➤ Sign Up |
| Cyprus | 2513 | ➤ Sign Up |
| Canada | 2479737 | ➤ Sign Up |
| New Zealand | 587658 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Follow DrugPatentWatch: